$0.83
+0.01 (+1.08%)
Open$0.80
Previous Close$0.82
Day High$0.85
Day Low$0.80
52W High$15.00
52W Low$0.56
Volume—
Avg Volume19.9K
Market Cap143.10M
P/E Ratio—
EPS$-0.17
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.46M | 45.50M | 43.44M |
| Net Income | 5.47M | 5.03M | 5.89M |
| Profit Margin | 12.3% | 11.1% | 13.6% |
| EBITDA | 8.24M | 9.46M | 8.95M |
| Free Cash Flow | 4.73M | 3.67M | 4.46M |
| Rev Growth | +4.4% | +9.5% | -0.1% |
| Debt/Equity | 0.49 | 0.48 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |